The permissive immune microenvironment is a critical regulator of disease progression from SMM to overt MM, and defining these alterations is critical for the development of translational prognostic and mechanistic models of disease progression

Basic Information

Funding Cycle : 2021-2022
Name : Jean-Baptiste Alberge
Type of Award : Career Development Award
Home Institution : Center for Research in Cancerology and Immunology Nantes-Angers, France
Host Institution : Dana-Farber Cancer Institute


ipsum lorem

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events